Valneva to Partner with Instituto Butantan on Single-Shot Chikungunya Vaccine for Low- and Middle- Income Countries

Valneva and Instituto Butantan, producer of immunobiologic products, today announced the signing of a binding term sheet for the development, manufacturing and marketing of Valneva‚Äôs single-shot chikungunya vaccine, VLA1553, in Low and Middle Income Countries (LMICs).

Read more